immune responses

In our tenth episode of the “Immuno Oncology Talks”,  we will discuss oncogenes in relation to immune responses with our guest, Professor Juha Klefström, from the Finnish Cancer Institute at the University of Helsinki, Finland. Professor Klefström is an expert in breast cancer biology and immuno-oncology, leading a research group focusing on oncogenes like Myc, in relation to the immune system and the tumour immune micro environment. 

For more information please visit :
Sanofi Immuno Oncology Talks website


MAT-BE-2400162 (ver.1 ) 02 2024 

In this episode, Hannah Imlay, MD, MS, discusses cytomegalovirus (CMV) prevention strategies in solid organ transplantation (SOT) recipients including:

• Strategies for preventing CMV in SOT
• International guideline recommendations for CMV prevention strategies by organ type
• Antivirals used for CMV prevention
• Comparison of preemptive therapy vs prophylaxis for CMV prevention in liver transplant recipients
• Comparison of letermovir vs valganciclovir for CMV prophylaxis in kidney transplant recipients
• Use of CMV cell–mediated immunity monitoring for primary prophylaxis
• Monitoring CMV viral loads, including limitations to quantitative nucleic acid testing
• Future prevention approaches

Faculty:

Hannah Imlay, MD, MS
Assistant Professor of Medicine
Department of Internal Medicine, Division of Infectious Diseases
University of Utah  
Salt Lake City, Utah

Content based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Follow along with a downloadable slideset at: 
https://bit.ly/476v2wI

Link to full program: 
https://bit.ly/47lNK2K

In this episode, Angela Branche, MD, and Helen Y. Chu, MD, MPH, discuss the clinical presentation of respiratory syncytial virus (RSV) in adults and the importance of early detection, including:  

• Clinical symptoms and presentation  
• Complications, including exacerbations of cardiopulmonary diseases
• Use of medical resources compared with other respiratory viruses
• Diagnostic approaches and challenges
• Treatment and management of RSV disease
• Clinical impact of RSV awareness

Faculty:  

Angela Branche, MD

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York

Helen Y. Chu, MD, MPH
Associate Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington  
School of Medicine
Seattle, Washington

Link to full program: 
bit.ly/3nb25xe

Link to downloadable slides:
bit.ly/3TsXym5